NED TALK 2021: Managing BTK Inhibitor–Related Adverse Events and Improving Adherence

Download All
A virtual Nursing Education Day focused on managing AEs and improving adherence in patients with cancer receiving BTK inhibitors, including live webinars with associated audio podcasts and downloadable slidesets.
Farrukh T. Awan, MD
Christopher R. Flowers, MD, MS
Nicole Lamanna, MD
John P. Leonard, MD
Julie M. Vose, MD, MBA

Interactive Decision Support Tool

Use this Interactive Decision Support Tool to see strategies to assess and manage adverse events associated with BTK inhibitors from 5 experts in managing patients with hematologic malignancies.


Farrukh T. Awan, MD Christopher R. Flowers, MD, MS Nicole Lamanna, MD John P. Leonard, MD Julie M. Vose, MD, MBA Released: June 9, 2021
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca
BeiGene, Ltd.
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Pharmacyclics LLC, An AbbVie Company

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings